Detalles de la búsqueda
1.
Postinduction molecular MRD identifies patients with NPM1 AML who benefit from allogeneic transplant in first remission.
Blood
; 143(19): 1931-1936, 2024 May 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-38364112
2.
Molecular, clinical and therapeutic determinants of outcome in NPM1 mutated AML.
Blood
; 2024 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38691678
3.
Successful outcome following allogeneic hematopoietic stem cell transplantation in adults with primary immunodeficiency.
Blood
; 131(8): 917-931, 2018 02 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-29279357
4.
Predictors of recovery following allogeneic CD34+-selected cell infusion without conditioning to correct poor graft function.
Haematologica
; 105(11): 2639-2646, 2020 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33131253
5.
Interleukin-1 blockade with anakinra in acute leukaemia patients with severe COVID-19 pneumonia appears safe and may result in clinical improvement.
Br J Haematol
; 190(2): e80-e83, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32438450
6.
Concerns about how to use established minimal residual disease monitoring in the treatment of NPM1-mutant acute myeloid leukaemia (AML) following reduced intensity chemotherapy protocols for AML given as a result of the COVID-19 pandemic.
Br J Haematol
; 190(4): e208-e210, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32609881
7.
Successful remission induction therapy with gilteritinib in a patient with de novo FLT3-mutated acute myeloid leukaemia and severe COVID-19.
Br J Haematol
; 190(4): e189-e191, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32584418
8.
The hOCT1 SNPs M420del and M408V alter imatinib uptake and M420del modifies clinical outcome in imatinib-treated chronic myeloid leukemia.
Blood
; 121(4): 628-37, 2013 Jan 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-23223357
9.
Wilms' Tumour 1 (WT1) peptide vaccination in patients with acute myeloid leukaemia induces short-lived WT1-specific immune responses.
Br J Haematol
; 164(3): 366-75, 2014 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-24422723
10.
Comparative analysis of melphalan versus busulphan T-cell deplete conditioning using alemtuzumab in unrelated donor stem cell transplantation for acute myeloid leukaemia.
Br J Haematol
; 187(1): e20-e24, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31396948
11.
Fludarabine, Cytarabine, Granulocyte Colony-Stimulating Factor, and Idarubicin With Gemtuzumab Ozogamicin Improves Event-Free Survival in Younger Patients With Newly Diagnosed AML and Overall Survival in Patients With NPM1 and FLT3 Mutations.
J Clin Oncol
; 42(10): 1158-1168, 2024 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38215358
12.
Risk-stratified adoptive cellular therapy following allogeneic hematopoietic stem cell transplantation for advanced chronic lymphocytic leukaemia.
Br J Haematol
; 160(5): 640-8, 2013 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-23293871
13.
Does BCR/ABL1 positive acute myeloid leukaemia exist?
Br J Haematol
; 161(4): 541-50, 2013 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-23521501
14.
A randomized comparison of CPX-351 and FLAG-Ida in adverse karyotype AML and high-risk MDS: the UK NCRI AML19 trial.
Blood Adv
; 7(16): 4539-4549, 2023 08 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-37171402
15.
FLT3 inhibitors as MRD-guided salvage treatment for molecular failure in FLT3 mutated AML.
Leukemia
; 37(10): 2066-2072, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37558736
16.
The role of Vδ2-negative γδ T cells during cytomegalovirus reactivation in recipients of allogeneic stem cell transplantation.
Blood
; 116(12): 2164-72, 2010 Sep 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-20576814
17.
HLA-mismatched unrelated donors are a viable alternate graft source for allogeneic transplantation following alemtuzumab-based reduced-intensity conditioning.
Blood
; 115(25): 5147-53, 2010 Jun 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-20371745
18.
Impact of in vivo alemtuzumab dose before reduced intensity conditioning and HLA-identical sibling stem cell transplantation: pharmacokinetics, GVHD, and immune reconstitution.
Blood
; 116(16): 3080-8, 2010 Oct 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-20587785
19.
Prognostic role of PET scanning before and after reduced-intensity allogeneic stem cell transplantation for lymphoma.
Blood
; 115(14): 2763-8, 2010 Apr 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-20124510
20.
Gilteritinib monotherapy as a transplant bridging option for high risk FLT3-mutated AML with t(6;9)(p23;q34.1);DEK-NUP214 in morphological but not cytogenetic or molecular remission following standard induction chemotherapy.
Leuk Res Rep
; 17: 100291, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35198371